针对小分子瘤向的细胞因子模仿物的特定网站化学修饰
Michael Mortensen1, Marco Bertolini1, Jacqueline Mock1
1Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), 8112 Zürich, Switzerland.
Bioconjugate chemistry
|July 18, 2023
概括
研究人员开发了一种新的方法,将小分子连接物连接到生物活性蛋白质上,改善癌症免疫治疗的向传递. 这种方法增强了瘤部位的蛋白质积累,同时保持了小结构大小.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 抗体和抗体碎片在癌症免疫疗法中常见于向蛋白质的输送,但由于大小,它们的组织透率可能很差.
- 小分子连接体为瘤选择性输送治疗性蛋白质 (如细胞因子) 提供了替代方案.
研究的目的:
- 开发一种单一的方法,用于特定地点的小分子与生物活性蛋白质的结合.
- 创建一个针对性的传递系统neoleukin-2/15 (Neo-2/15) 使用一个小分子联体增强瘤中的积累.
主要方法:
- 在蛋白质上,在含有的小分子和N终端的囊蛋白之间形成 thiazolidine 的单程序.
- 氨基-2/15 (Neo-2/15),一种人工合成的氨基-2和-15模仿剂,与乙胺加,一种碳酸无水酶IX (CAIX) 配体结合.
主要成果:
- Neo-2/15和乙胺加结合物保留了Neo-2/15的生物活性.
- 结合剂在静脉注射后在细胞癌 (SK-RC-52) 异位移植中显示累积.
- 这项研究强调了小分子向的潜力,以增强蛋白质货物向疾病部位的递送.
结论:
- 小分子蛋白结合物为向癌症免疫治疗提供了一个有希望的策略.
- 这种方法允许选择性地将治疗性蛋白质输送到瘤中,同时保持小分子大小,以更好地透组织.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.5K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567